Next Article in Journal
Self-Replicating RNA Viruses for Vaccine Development against Infectious Diseases and Cancer
Next Article in Special Issue
Characterization of Individuals Interested in Participating in a Phase I SARS-CoV-2 Vaccine Trial
Previous Article in Journal
Pharmaceutical Industry’s Engagement in the Global Equitable Distribution of COVID-19 Vaccines: Corporate Social Responsibility of EUL Vaccine Developers
Previous Article in Special Issue
Course and Lethality of SARS-CoV-2 Epidemic in Nursing Homes after Vaccination in Florence, Italy
 
 
Article

Article Versions Notes

Vaccines 2021, 9(10), 1186; https://doi.org/10.3390/vaccines9101186
Action Date Notes Link
article pdf uploaded. 15 October 2021 11:59 CEST Version of Record https://www.mdpi.com/2076-393X/9/10/1186/pdf-vor
article supplementary file uploaded. 15 October 2021 11:59 CEST - https://www.mdpi.com/2076-393X/9/10/1186#supplementary
article xml file uploaded 18 October 2021 14:26 CEST Original file -
article xml uploaded. 18 October 2021 14:26 CEST Update -
article pdf uploaded. 18 October 2021 14:26 CEST Updated version of record https://www.mdpi.com/2076-393X/9/10/1186/pdf-vor
article xml file uploaded 18 October 2021 14:28 CEST Update -
article html file updated 18 October 2021 14:28 CEST Original file -
article xml uploaded. 18 October 2021 14:28 CEST Update https://www.mdpi.com/2076-393X/9/10/1186/xml
article pdf uploaded. 18 October 2021 14:28 CEST Updated version of record https://www.mdpi.com/2076-393X/9/10/1186/pdf
article html file updated 18 October 2021 14:29 CEST Update -
article html file updated 30 July 2022 11:05 CEST Update https://www.mdpi.com/2076-393X/9/10/1186/html
Back to TopTop